This document may differ from the final, published version of the research and has been made available online in accordance with publisher policies. To read and/or cite from the published version of the research, please visit the publisher's website (a subscription may be required.) (OPN) is a phosphorylated acidic glycoprotein that can function as both an extracellular matrix molecule and a cytokine. Published data support that OPN is upregulated in surgical lung tissue samples of patients with COPD. Th e aim of this study was to determine the levels of OPN in sputum supernatants of patients with COPD and to investigate possible associations with mediators and cells involved in the infl ammatory and remodeling process as well as with the extent of emphysema.
COPD is a destructive lung disorder characterized by infl ammatory and tissue remodeling processes that is associated with a chronic enhanced infl ammatory response in the airways and the lung to noxious particles or gases. Pathologic features of COPD are pulmonary infl ammation, remodeling-like changes in mucosal lung tissue, fi brosis, and tissue injury. 1 Although considerable information has been gathered concerning the role of diff erent agents in the promotion of infl ammation and airway destruction in the acute setting of the disease, relatively little is known about signaling pathways that drive their progressive and chronic nature. 2 Osteopontin (OPN) is a phosphorylated acidic glycoprotein that can function both as an extracellular matrix molecule and as a cytokine. Its origin is not well clarifi ed, but epithelial cells, macrophages, T cells, and fi broblasts have been shown to express OPN. Limited data are available regarding OPN in COPD. Adenosine deaminase-defi cient mice develop alveolar airspace enlargement that resembles histologic fi ndings of patients with emphysema. 3 OPN has been found to be associated with alveolar airspace enlargement, neutrophilia, and elevations of mediators of airspace enlargement such as matrix metalloproteinases (MMPs) in adenosine deaminase-defi cient mice. 3, 4 Given that the majority of OPN immunolocalization in human COPD lung samples was in alveolar macrophages and that OPN expression was associated with the severity of airfl ow obstruction, it was suggested that OPN may be a major mediator of emphysema. 4 We have reported that sputum OPN levels are higher in patients with asthma who smoke compared with patients with asthma who are nonsmokers and in patients with severe refractory asthma compared with less severe forms of the disease. 5, 6 Th e aim of the present study was to evaluate the levels of OPN in sputum supernatants of patients with COPD in comparison with healthy smokers and nonsmoking subjects. We hypothesized that sputum OPN would be elevated in patients with COPD compared with healthy control subjects and that it would be associated with infl ammatory cells and mediators involved in the ongoing airway infl ammation process observed in COPD. We also hypothesized that OPN levels would be associated with the extent of emphysema.
Materials and Methods

Subjects
Patients with COPD were recruited aft er extensive evaluation from an open cohort of patients with COPD who were followed in the outpatient clinics of the 1st and 2nd Respiratory Medicine Departments of the University of Athens Medical School. Initially, 94 patients were evaluated. The diagnosis of COPD and the severity of airflow obstruction was established according to the GOLD (Global Initiative for Chronic Obstructive Lung Disease) guidelines. 7 Patients had a history of smoking ( . 20 pack-years) and irreversible airflow limitation (reversibility , 12% and , 200 mL in FEV 1 aft er b 2 -agonist inhalation). Subjects with a malignant disease were excluded. All patients were clinically stable, with no evidence of acute exacerbation for at least 4 weeks prior to enrollment. Twenty healthy nonsmokers and 20 healthy smokers served as control subjects. Th e healthy subjects were recruited from the staff of both departments and have also been used as a control group in previous studies of our group. 5 Th e study was approved by the ethics committees of both hospitals (Sotiria Hospital and Attikon Hospital Ethics Committee No:517/May 2008), and all subjects provided written informed consent.
Study Design
On day 1, all subjects underwent medical history and physical examination by a dedicated respiratory physician, lung function measurements, and measurement of BMI, and all patients with COPD underwent highresolution CT (HRCT) scan of the chest. On day 2, sputum induction was performed. All measurements were performed between 8.00 am and 10.00 am . All smokers refrained from smoking for at least 2 h, under supervision of one of the study coordinators. HRCT scans were performed as part of the medical assessment of patients with COPD. Patients with fi ndings suspicious for malignancies or nondefi ned conditions were excluded.
Induced Sputum
Sputum was induced as previously described, using all necessary modifications for safe measurements according to the underlying airflow obstruction. 8 Sputum was processed using selected plugs as previously described. 9 Dithiothreitol was added in a volume equal to four times the weight of the sputum specimen, and it was further diluted with phosphatebuffered saline in a volume equal to the sputum plus dithiothreitol. Total cell counts were performed on a hemocytometer using Trypan blue stain. Slides were prepared by cytospin (Th ermo Fisher Scientifi c Inc ) and were stained with May-Grunwald and Giemsa for diff erential cell counts. Cell counting was performed by an observer blind to the clinical characteristics of the subjects. At least 500 infl ammatory cells were counted in each sample. A sample was considered adequate when the patient was able to expectorate at least 2 mL of sputum and the slides contained , 10% squamous cells on diff erential cell counting. Th e total cell count (expressed as the number of cells 3 10 6 ) and the percentage of sputum infl ammatory cells was used for analysis. Sputum supernatants were kept at 2 70°C for further measurement of OPN, transforming growth factor (TGF)-b 1 , MMP-2, IL-8, and leukotriene B4 (LTB4) (e-Appendix 1).
Lung Function
FEV 1 , FVC, FEV 1 /FVC ratio, static volumes (functional residual capacity), and diff using capacity of the lung for carbon monoxide (D lco ) corrected for hemoglobin levels were measured using a commercially available system (MasterScreen Body; CareFusion Corporation), according to the American Th oracic Society guidelines. 10, 11 Mediator Assays MMP-2 (free) and IL-8 were measured using an enzyme-linked immunosorbent assay (ELISA) kit (R&D Systems, Inc) with detection limits of 3.5 pg/mL and 0.047 ng/mL, respectively. LTB4 was measured with an ELISA kit (Cayman Chemical Company). TGF-b 1 and human OPN were measured by ELISA kits (R&D Systems, Inc) with lower detection limits of 50 pg/mL and 6 pg/mL, respectively. All values were expressed as pg/mL. Th e intraassay and interassay variability were assessed according to the manufacturers' instructions for all the mediators measured and were within acceptable coefficient of variation (%). For OPN, the intraassay and interassay variabilities were 4% and 6.5%, respectively. Th e recovery and linearity of the assays aft er appropriate spiking experiments produced samples with values within the dynamic range of the assay.
Quantifi cation of Emphysema in Patients With COPD
All patients with COPD were submitted to HRCT scan of the chest using a Philips Brilliance 64 (Koninklijke Philips N.V.). Th e degree of emphysema was calculated by an experienced radiologist using a visual emphysema score as previously described. 12 Th e presence of emphysematous lesions involving . 15% of the pulmonary parenchyma were used for the characterization of the emphysematous COPD phenotype, as previously described. 13 
Statistical Analysis
Normally distributed data are presented as mean Ϯ SD, and skewed data are presented as median (interquartile range). Normality of distribution was checked with Kolmogorov-Smirnov test. Statistical comparisons between groups were performed with one way analysis of variance for normally distributed data and Kruskal-Wallis tests for skewed data, accompanied by appropriate post hoc tests for multiple comparisons (Bonferroni and Dunnett, respectively). Diff erences in numerical variables between two groups were evaluated with unpaired t tests or MannWhitney U tests for normally distributed and skewed data, respectively, whereas comparisons of proportions were performed using x 2 tests. To examine the associations between OPN, sputum cells, mediators (IL-8, TGF-b 1 , MMP-2, LTB4), lung function tests, and emphysema score, linear regression analysis was performed using OPN as the dependent variable, after proper adjustments for age, sex, BMI, smoking habit (in pack-years), Charlson comorbidity index score, duration of the disease, and treatment regimens. Data were interpreted as standardized coeffi cients with 95% CIs. P values , .05 (two-sided) were considered statistically signifi cant. Statistical analysis was performed using SPSS 16.0 (IBM) and GraphPad Prism 5 (GraphPad Soft ware, Inc).
Results
Demographic Characteristics
Figure 1 presents the fl owchart of patients with COPD included in the study. Seventy-seven patients with COPD and 40 healthy subjects (20 smokers) were included in the study. Forty-one patients with COPD were receiving 1,000 m g fl uticasone/d or equivalent. Forty-nine patients were receiving long-acting b 2 -agonists, and 61 were receiving tiotropium. Sputum induction was well tolerated by all patients. Th e demographic characteristics of the study population are summarized in Table 1 .
Infl ammatory Variables in Induced Sputum
Patients' infl ammatory variables are summarized in Table 2 . OPN levels (pg/mL) were signifi cantly higher in patients with COPD compared with both smoking and nonsmoking healthy subjects (median [ Table 2 ) .
Associations of OPN
All the signifi cant associations were observed only in patients with COPD. No association was observed in the healthy smoking and nonsmoking subjects (data not shown ).
Infl ammatory Biomarkers:
Regression analysis aft er proper adjustments provided signifi cant associations between log OPN levels and sputum neutrophils. Moreover, signifi cant associations were also provided between log OPN levels and IL-8 and MMP-2 ( Table 3 ) .
Emphysema Score: Using regression analysis aft er proper adjustments a signifi cant association was observed between log OPN levels and emphysema score ( Table 3 ) .
Lung Function:
No signifi cant associations between OPN and lung function tests were observed in any of the study groups ( Table 3 , for patients with COPD). Stepwise regression analysis showed that MMP-2 and emphysema score represented the strongest associations with OPN ( R 2 5 0.59, P , .001 and R 2 5 0.51, P 5 .001, respectively).
Discussion
Th e major fi nding of the present study is that OPN levels in sputum supernatants are signifi cantly higher in patients with COPD compared with both smoking and nonsmoking healthy subjects. Sputum OPN levels were also positively associated with sputum neutrophils, IL-8, MMP-2, and emphysema score in patients with COPD. Th is is the fi rst study, to our knowledge, that has evaluated the levels of OPN in the sputum of patients with COPD OPN has been shown to be involved in processes related to smoking habit. A previous study has found that the expression of OPN was highly induced in macrophages from BAL fl uid of smokers and that increased expression levels correlated with lung function impairment in this study group. 14 Moreover, Prasse et al, 15 assessed the essential role of OPN in smoking-related interstitial lung diseases, showing that BAL cells from patients with pulmonary Langerhans cell histiocytosis or desquamative interstitial pneumonitis spontaneously produced abundant amounts of OPN. In the same study, BAL cells from healthy smokers produced 15-fold less OPN, and those from nonsmoking healthy volunteers produced no OPN, suggesting a possible pathogenic role of OPN in both pulmonary Langerhans cell histiocytosis and desquamative interstitial pneumonitis. In a previous study of our group, sputum OPN was higher in smoking compared with nonsmoking subjects with asthma, and it was positively associated with sputum neutrophils, TGF-b 1 , and IL-8, suggesting a possible role for OPN in the neutrophilic infl ammation and the remodelling process in patients with asthma who smoke. 5 OPN levels have also been associated with alveolar airspace enlargement, as shown by Schneider et al 4 in a model of COPD Ada 2 / 2 double-knockout mice. In that study, Ada 2 / 2 mice exhibited OPN-dependent neutrophilia, alveolar airspace enlargement, and increases in mediators of airspace enlargement, such as MMP-9 and its corresponding tissue inhibitor TIMP-1. Th e authors of this study additionally showed that patients with COPD had increased OPN expression within distal airways that was associated with clinically relevant airway obstruction. 4 Although we did not fi nd any correlation between OPN levels and lung function parameters, our results are compatible with the previously defi ned fi ndings toward the direction of a possible role of OPN in the induction of neutrophilic infl ammation and the pathogenesis of emphysema in COPD.
Confl icting data exist regarding the interaction between OPN and TGF-b 1 , as it has been shown that OPN is a TGF-b 1 response gene but also that it may function Regression analysis was performed after proper adjustments for age, sex, BMI, smoking habit (current or former smokers and pack-y), and treatment regimens. See Table 1 and 2 legends for expansion of abbreviations. a P , .05 considered statistically signifi cant.
upstream of TGF-b 1 by regulating its activation in lung fi brosis. 16, 17 Our study failed to reveal an association between TGF-b 1 and OPN. On the other hand, it has been shown that TGF-b induces the secretion and activation of the proteolytic enzyme MMP-2, and, conversely, TGF-b can also be activated by a number of proteases, including MMP-2. 18, 19 Moreover, in another study it was suggested that TGF-b 1 signaling may prevent emphysema development by inhibiting MMP-mediated elastin degradation or by promoting synthesis of elastin. 20 MMP-2 expression has been found to be elevated in the lung parenchyma of patients with COPD compared with smoking and nonsmoking healthy subjects, and such an upregulation has been related to disease severity, implying a possible role of MMP-2 in airway remodeling in COPD. 21, 22 Additionally, other studies have demonstrated increased gelatinolytic activity linked to sputum MMP-2 and a negative correlation of induced sputum MMP-2 with airway obstruction in patients with COPD. 23, 24 In accordance with the described studies, our results showed higher induced sputum MMP-2 levels in patients with COPD compared with the other two groups. Moreover, Berman et al 17 showed that MMP-2 expression may be regulated by OPN during lung injury in vivo in a model of murine bleomycin-induced lung fi brosis. In accordance with these fi ndings, our data suggest a role of OPN through MMP-2 in the infl ammatory process in the lungs of patients with COPD. However, since the activation of MMP-2 is a complex process, a more detailed evaluation including measurement of the levels of tissue inhibitor of metalloproteinase-2 might be necessary to extract safe conclusions.
An interesting fi nding of the present study is the correlation of OPN levels to the extent of emphysema, as defi ned by the emphysema score calculated in HRCT scans. Th e explanation of such a relation between a measurable marker in induced sputum supernatant and a score yielded from a radiologic evaluation requires caution. However, this association of OPN with emphysema may be mediated through MMP-2, a cytokine we also found to be associated with OPN. Moreover, a study demonstrated that the gene for OPN was highly expressed in the lung antigen-presenting cells of smokeexposed mice and was required for the development of emphysema in vivo through T(H)17 inflammatory responses, thus, providing a possible mechanism for the induction of emphysema. 25 However, it has to be stressed that the association between OPN and parenchymal destruction is rather speculative, although the fact that it was present in the detailed regression analysis after correction for all possible confounders is supportive of this relationship. Th e extremely low OPN levels in both smoking and nonsmoking healthy subjects may be attributed to the absence and/or inactivation of OPN-producing cells. In the present study, OPN was positively associated with sputum neutrophils and IL-8. Th e association of OPN with sputum neutrophils observed in patients with COPD is compatible with neutrophilic airway infl ammation as a major factor in the pathogenesis of the disease. 26 Moreover, the association of OPN with IL-8, which is the major chemoattractant for neutrophils, provides an explanation for the traffi cking of neutrophils in the airways and the sputum of patients with COPD. In a previous study in an experimental model of colitis, defective recruitment of neutrophils was observed in OPN-null mice, whereas the addition of exogenous OPN was associated with a robust increase in peritoneal infi ltration of neutrophils. 27 Accordingly, OPN could also be directly associated with neutrophilic chemotaxis apart from IL-8. Th ese fi ndings support the importance of OPN in the recruitment of neutrophils and that OPN is a relevant mediator of neutrophil chemotaxis.
Th e absence of correlation between OPN and lung function points toward a lack of association of OPN with airway obstruction severity. However, this may be attributed to the fact that the number of patients with COPD evaluated is rather small to draw safe conclusions about the diff erent disease stages according to airway obstruction. Additionally, airfl ow limitation as expressed by FEV 1 , is the composite terminal eff ect of various pathogenic mechanisms in COPD, including infl ammation, remodeling, and fi brosis. Previous studies have shown associations between the degree of airfl ow obstruction and OPN expression in alveolar macrophages of smokers 14 and OPN expression in human surgical lung tissue samples from patients with COPD. 4 Diff erences in sampling material-induced sputum vs BAL and lung biopsies-may account for the discrepancy of our fi ndings with the previously discussed studies. Interestingly, of all the associations with lung function parameters, the only one presenting a trend toward statistical signifi cance with sputum OPN levels was D lco ( P 5 .059). Despite the fact that the association between D lco and the extent of emphysema is rather weak, this fi nding may further support the association between OPN and the extent of parenchymal destruction in patients with COPD. Furthermore, it has been reported that any associations between D lco and infl ammatory biomarkers in patients with predominant emphysema are mainly related to the infl ammatory phenotype observed in small airways. 28 Th is study presents limitations. First, the cross-sectional design does not allow us to provide long-term follow-up data of the patients. A prospective cohort study evaluating the importance of sputum OPN as a predictive biomarker of clinically relevant outcomes (eg, exacerbations, hospitalizations, and/or mortality) should be specifi cally designed for that purpose. Second, the absence of biopsy specimens did not allow us to investigate structural changes in the airways of patients with COPD and their associations with OPN levels. However, the fact that sputum OPN presented signifi cant associations with emphysema score and particular sputum biomarkers related to infl ammation and remodeling, which remained even aft er proper adjustments for confounders, provides important evidence about the possible role of OPN in these processes. Finally, the results of our cross-sectional study cannot rule out the possibility that OPN is not causal or pathophysiologically related to COPD but rather a surrogate marker of infl ammation, specifi c to neither obstructive disease nor neutrophilic infl ammation.
Conclusions
OPN levels are signifi cantly elevated in the induced sputum of patients with COPD, compared with smoking and nonsmoking healthy control subjects. Th e associations of OPN with sputum neutrophils, IL-8, MMP-2, and emphysema score in patients with COPD suggest a possible role for OPN in the induction of neutrophilic infl ammation and the pathogenesis of emphysema in COPD. Given the possible implication of OPN in the regulation of multiple processes that promote the pathogenesis of COPD, our fi ndings suggest that OPN may represent an attractive novel biomarker that may serve as a possible therapeutic target.
